IVVD
Invivyd, Inc.
Overview
Invivyd, Inc is a Healthcare company operating in Biotechnology with a $269.4M market cap.
IVVD missed consensus EPS by 1.0% in Q1 FY2026, reported May 6, 2026.
12 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-144 Q&A exchanges
- Q4 FY2025Earnings2026-03-056 Q&A exchanges
- Q3 FY2025Earnings2025-11-065 Q&A exchanges
- Q1 FY2025Earnings2025-05-154 Q&A exchanges
- Q3 FY2024Earnings2024-11-1411 Q&A exchanges
- Q2 FY2024Earnings2024-08-149 Q&A exchanges
- Q1 FY2024Earnings2024-05-094 Q&A exchanges
- Q3 FY2023Earnings2023-11-129 Q&A exchanges
- Q2 FY2023Earnings2023-08-128 Q&A exchanges
- Q1 FY2023Earnings2023-05-116 Q&A exchanges
- Q4 FY2022Earnings2023-03-257 Q&A exchanges
- Q3 FY2022Earnings2022-11-139 Q&A exchanges
History
Earnings history
- Q1 FY20262026-05-06EPS$-0.13 vs $-0.06-100.0%Rev$13.7M vs ——EODHD
- Q4 FY20252026-03-25EPS$-0.04 vs $-0.09+54.5%Rev$17.2M vs ——EODHD
- Q3 FY20252025-11-05EPS$-0.06 vs $-0.07+14.3%Rev$13.1M vs ——EODHD
- Q2 FY20252025-08-14EPS$-0.12 vs $-0.02-100.0%Rev$11.8M vs ——EODHD
- Q1 FY20252025-05-14EPS$-0.14 vs $-0.04-100.0%Rev$11.3M vs ——EODHD
- Q4 FY20242025-03-25EPS$-0.15 vs $-0.10-50.0%Rev$13.8M vs ——EODHD
- Q3 FY20242024-11-06EPS$-0.51 vs $-0.35-45.7%Rev$9.3M vs ——EODHD
- Q2 FY20242024-08-13EPS$-0.40 vs $-0.37-8.1%Rev$2.3M vs ——EODHD
- Q1 FY20242024-05-08EPS$-0.38 vs $-0.47+19.1%Rev$0 vs ——EODHD
- Q4 FY20232024-03-27EPS$-0.67 vs $-0.42-59.5%Rev$3.0M vs ——EODHD
- Q3 FY20232023-11-08EPS$-0.36 vs $-0.50+28.0%Rev$0 vs ——EODHD
- Q2 FY20232023-08-09EPS$-0.46 vs $-0.34-35.3%Rev$0 vs ——EODHD
- Q1 FY20232023-05-10EPS$-0.32 vs $-0.30-6.7%Rev$0 vs ——EODHD
- Q4 FY20222023-03-22EPS$-0.25 vs $-0.39+35.9%Rev$0 vs ——EODHD
- Q3 FY20222022-11-09EPS$-0.42 vs $-0.49+14.3%Rev$0 vs ——EODHD
- Q2 FY20222022-08-14EPS$-0.47 vs $-0.57+17.5%Rev$0 vs ——EODHD
- Q1 FY20222022-05-12EPS$-0.93 vs $-0.82-13.4%Rev$0 vs ——EODHD
- Q4 FY20212022-03-29EPS$-0.77 vs $-1.03+25.2%Rev$0 vs ——EODHD
- Q3 FY20212021-11-14EPS$-0.98 vs $-0.74-32.4%Rev$3 vs ——EODHD
- Q2 FY20212021-09-19EPS$-0.18 vs $-0.80+77.5%Rev$0 vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-05-06 | $-0.13 | $-0.06 | -100.0% | $13.7M | — | — | EODHD |
| Q4 FY2025 | 2026-03-25 | $-0.04 | $-0.09 | +54.5% | $17.2M | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $-0.06 | $-0.07 | +14.3% | $13.1M | — | — | EODHD |
| Q2 FY2025 | 2025-08-14 | $-0.12 | $-0.02 | -100.0% | $11.8M | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-0.14 | $-0.04 | -100.0% | $11.3M | — | — | EODHD |
| Q4 FY2024 | 2025-03-25 | $-0.15 | $-0.10 | -50.0% | $13.8M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.51 | $-0.35 | -45.7% | $9.3M | — | — | EODHD |
| Q2 FY2024 | 2024-08-13 | $-0.40 | $-0.37 | -8.1% | $2.3M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.38 | $-0.47 | +19.1% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-27 | $-0.67 | $-0.42 | -59.5% | $3.0M | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $-0.36 | $-0.50 | +28.0% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.46 | $-0.34 | -35.3% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-0.32 | $-0.30 | -6.7% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-22 | $-0.25 | $-0.39 | +35.9% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.42 | $-0.49 | +14.3% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-14 | $-0.47 | $-0.57 | +17.5% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-12 | $-0.93 | $-0.82 | -13.4% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-03-29 | $-0.77 | $-1.03 | +25.2% | $0 | — | — | EODHD |
| Q3 FY2021 | 2021-11-14 | $-0.98 | $-0.74 | -32.4% | $3 | — | — | EODHD |
| Q2 FY2021 | 2021-09-19 | $-0.18 | $-0.80 | +77.5% | $0 | — | — | EODHD |
Source: EODHD. IVVD reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks IVVD's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.77 | $4.10 | +16.3% | +2.5% | +3.3% |
| Q4 FY2026 | $5.24 | $4.33 | +21.0% | -1.8% | -4.6% |
| Q3 FY2026 | $5.26 | $4.18 | +25.8% | -4.0% | -2.5% |
| Q2 FY2026 | $5.59 | $4.43 | +26.2% | -0.4% | +2.4% |
| Q1 FY2025 | $4.85 | $4.30 | +12.8% | -6.7% | -3.9% |
| Q4 FY2025 | $5.15 | $4.25 | +21.1% | -3.7% | -1.9% |
| Q3 FY2025 | $5.05 | $4.46 | +13.3% | -3.8% | -4.9% |
| Q2 FY2025 | $4.78 | $4.26 | +12.3% | -4.1% | -4.6% |
| Q1 FY2024 | $5.05 | $4.40 | +14.7% | +3.4% | +3.9% |
| Q4 FY2024 | $5.13 | $4.47 | +14.7% | -4.2% | -6.9% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- William E DukeCFO1 yr 4 mo8 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance cut Q2 FY2026
- Robert D Allen IIIChief Scientific Officer1 yr 4 mo4 callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance raise Q2 FY2026
- Jill AndersenChief Legal Officer, Secretary1 yr 4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last guidance cut Q2 FY2026
- Timothy Edward LeeChief Commercial Officer2 yrno recorded callsCurrentSample
OTHER_C_SUITE since 2024 • 5/8 beats (63%) • last call held guidance Q2 FY2026
- Julie GreenChief Human Resources Officer1 yr 4 mono recorded callsCurrentSample
OTHER since 2025 • 2/4 beats (50%) • last guidance cut Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for IVVD.
$ curl https://api.spokenalpha.com/v1/companies/IVVDFAQ
Frequently asked about IVVD
Where can I find Invivyd, Inc.'s (IVVD) earnings call transcripts?
Spoken Alpha indexes IVVD's earnings call transcripts at https://spokenalpha.com/companies/IVVD. Each call links to attributed speakers and parsed analyst Q&A. Invivyd, Inc.'s own investor relations page is at https://investors.invivyd.com/.
When was Invivyd, Inc.'s most recent earnings call?
Invivyd, Inc. (IVVD) held its most recent earnings call on 2026-05-14, covering fiscal Q1 2026.
What sector is IVVD in?
Invivyd, Inc. (IVVD) operates in the Healthcare sector (Biotechnology industry).